This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Lemon Balm
Melissa officinalis (lemon balm) is a Lamiaceae-family herb used for two and a half millennia as a calming/digestive folk remedy, now a member of the modern "first-tier behavioral-lever" anxiolytic…
Aliases (1)
Overview
What is Lemon Balm?
Melissa officinalis (lemon balm) is a Lamiaceae-family herb used for two and a half millennia as a calming/digestive folk remedy, now a member of the modern "first-tier behavioral-lever" anxiolytic shelf alongside L-theanine, chamomile, and passionflower. Mechanism is twofold: rosmarinic acid inhibits GABA transaminase (the enzyme that degrades synaptic GABA), and lipophilic terpenes (citronellal, citral) plus flavonoids bind GABA-A and possibly muscarinic/nicotinic receptors. Human RCT evidence is mild-to-moderate but consistent across heart palpitations (Alijaniha 2015), mild-to-moderate anxiety + sleep disturbance (Cases 2011), laboratory-induced acute stress (Kennedy 2002, 2004), Alzheimer's disease agitation (Akhondzadeh 2003), and topical HSV-1 cold sores (Koytchev 1999, Anheyer 2025). Effect size is modest — anyone expecting a benzo replacement will be disappointed; anyone expecting a gentle subjective "exhale" before bed or before a high-stakes meeting will probably notice it. For Dylan (20yo MMA athlete + business owner, night-owl, zero caffeine baseline): OPTIONAL-ADD. Reasonable evening wind-down adjunct, especially stacked with L-theanine or chamomile when pre-bed sympathetic tone is elevated by training-stress or business-stress carry-over. Standardized extract (3-7% rosmarinic acid) at 300-600 mg, 30-60 min pre-sleep, or split AM/PM for daytime anxiolysis. Phytosome (Relissa-style) at 250-500 mg if bioavailability is a concern (rosmarinic acid oral BA ~4%). Very safe profile. Watch for: mild hypothyroid signal (animal data), CYP3A4 mild inhibition (theoretical), paradoxical insomnia in a minority (dose- and timing-dependent).
Research Indications
GABA-A receptor positive allosteric modulation
weak but measurable; contributes to the sedative tier at higher doses.
Nicotinic and muscarinic acetylcholine receptor binding
Kennedy/Wake et al. (PMID 12888775, *Neuropsychopharmacology* 2003) showed displacement of [³H]-(N)-nicotine and [³H]-(N)-scopolamine bin…
β-adrenergic modulation
rosmarinic acid + flavonoid fraction has mild peripheral sympatholytic effect, likely explaining the heart-palpitation reduction in Alija…
Caffeic acid (a metabolite + co-occurring polyphenol): ~14.7% oral BA
somewhat better.
CYP3A4 mild inhibition
reported in vitro for some lemon balm extracts. Clinical significance is low at typical doses but theoretical caveat for CYP3A4 substrates.
Research Protocols
Disclaimer: These are commonly discussed research protocols and not medical advice.
Peptide Interactions
(200 mg) — community's #1 co-mention (246 dc reports). Mechanistic complement (theanine = mild α2/glutamate modulation + α-wave EEG; lemon balm = GABA-T inhi…
(200-400 mg apigenin-standardized) — apigenin is a partial benzodiazepine-site GABA-A modulator; complementary mild anxiolysis. Classic "bedtime tea" stack w…
(250-500 mg) — chrysin + other flavonoid GABA-A PAMs; complementary mechanism; mild additive sedation.
GABA-A PAM + cortisol reduction; reasonable evening stack for the "high-cortisol night-owl" use case Dylan may encounter on heavy-business or post-spar nights.
at low-to-moderate doses (≤300-500 mg of root extract; Cerny 1999 / German E Commission–consistent dosing) — synergistic sleep onset. Cap combined dose — Ken…
community co-mention #4 (93 reports); GABA oral BA is poor, so the rationale is weak, but the subjective stack is popular and at typical doses is benign.
(3 g pre-sleep) — mild sleep-onset hypothermia + parasympathetic shift; complementary to lemon balm's central GABAergic effect.
additive GABAergic CNS depression. The downside risk in Dylan's archetype is low (no current Rx anxiolytic use) but worth knowing if anyone in his future ove…
additive sedation; Dylan's profile is zero-alcohol baseline, so not directly relevant.
usually fine but can produce excessive next-morning sedation; if stacking three anxiolytics, reduce each individually.
community dc data flags 11 serotonin-syndrome mentions. The mechanistic basis is thin (lemon balm is not a primary serotonergic agent), but defaulting to cau…
theoretical signal from animal studies of mild TSH/T4 suppression. Take lemon balm 4+ hours apart from levothyroxine to minimize any potential interaction. N…
What to Expect
- Onset30-60 min oral; lemon balm tea slightly faster due to fluid + thermal vehicle.
- Peaksubjective effect 60-90 min.
Side Effects & Safety 6
Side Effects
- 1Mild drowsiness — especially at >600 mg or in stimulant-naive users (Dylan's profile: zero caffeine baseline, so probably more sensitive).
- 2GI mild — occasional nausea or gastric upset from concentrated tannins/polyphenols; rare in standardized extract, more common with crude leaf at high doses or as concentrated tea.
- 3Mild headache — small minority; usually fades within first few doses.
- 4Paradoxical stimulation / insomnia at higher doses or wrong timing — community-reported (46 dc reports); likely the biphasic cholinergic effect (Kennedy 2002 / 2003) — at high doses lemon balm shifts toward anticholinergic/stimulant profile in a subset of users.
- 5Paradoxical anxiety at very high single doses (>900 mg standardized extract) — Kennedy 2006 high-dose paradox; uncommon at typical use.
- 6Mild fatigue / next-day grogginess — usually formulation- or dose-related; fades with dose reduction.
When to Stop
- No reported hepatotoxicity in the human literature. Mild transient transaminase elevations at very high chronic doses in animal models; not clinically documented in humans.
- Possible mild hypothyroid signal — animal data show modest reductions in TSH and T4 with chronic high-dose Melissa extract (in vitro inhibition of TSH receptor binding by rosmarinic acid + radical-binding to thyroid peroxidase substrates). Clinical relevance for normal-thyroid users is minimal at typical doses. Practical caveat: if Dylan ever develops hypothyroidism (no current indication) or is taking thyroid hormone replacement, retest TSH after 8-12 weeks of daily lemon balm use to confirm no shift.
- Allergic reactions — rare; reported topical contact dermatitis from cream formulations and rare oral hypersensitivity. Lamiaceae cross-reactivity is theoretical (mint, oregano, sage family).
- First 1-2 doses: Calibrate response — assess for paradoxical stimulation vs intended calming effect. If the first 300 mg dose feels stimulating rather than calming, drop to 150 mg or switch to tea preparation.
- First 4 weeks chronic use: Monitor sleep onset latency; if it worsens rather than improves, lemon balm is in the "stimulating subset" of your phenotype and should be moved to daytime PRN use rather than pre-sleep.
- Long-term chronic daily use (>3 months): No documented adverse trajectory; periodic TSH at annual physical sufficient.
References
Cases et al. 2011 — Pilot trial of Melissa officinalis L. leaf extract for anxiety + sleep disturbance (PMID 22207903)
open-label Cyracos® 600 mg/day, 15 days, n=20.
View StudyAlijaniha et al. 2015 — Heart palpitation relief with Melissa officinalis leaf extract: DBPC RCT (PMID 25680840)
1000 mg/day, 14 days, n=71.
View StudyKennedy et al. 2002 — Modulation of mood and cognitive performance following acute Melissa officinalis (PMID 12062586)
single-dose 300/600/900 mg crossover; biphasic dose-response.
View StudyKennedy et al. 2003 — Melissa officinalis with CNS nicotinic + muscarinic receptor binding (PMID 12888775)
mechanism + clinical effect replication.
View StudyKennedy et al. 2004 — Attenuation of laboratory-induced stress by Melissa officinalis (PMID 15272110)
DISS paradigm acute stress-buffering at 600 mg.
View StudyKennedy/Little/Haskell 2006 — Anxiolytic effect of Melissa + Valeriana combination (PMID 16444660)
high-dose paradox demonstrated.
View StudyAwad et al. 2009 — Bioassay-guided fractionation of Melissa officinalis GABA transaminase activity (PMID 19165747)
central mechanism paper; rosmarinic + ursolic acid identified as principal GABA-T inhibitors.
View StudyIbarra et al. 2010 — Chronic Melissa officinalis effects on anxiety + circadian activity in mice (PMID 20171069)
chronic-dosing animal evidence.
View StudyYoo et al. 2011 — Melissa officinalis neurogenesis + corticosterone + GABA in mouse dentate gyrus (PMID 21076869)
chronic-stress mechanism support.
View StudyAkhondzadeh et al. 2003 — Melissa officinalis in mild-to-moderate Alzheimer's: DBPC RCT (PMID 12810768)
4-month cognitive + agitation benefit.
View StudyJavid/Haybar et al. 2018 — Melissa officinalis in chronic stable angina, oxidative stress + lipid profile (PMID 30045422)
polyphenol antioxidant mechanism in cardiovascular context.
View StudyKoytchev et al. 1999 — Balm mint extract (Lo-701) topical for herpes labialis (PMID 10589440)
foundational HSV-1 RCT.
View StudyAnheyer et al. 2025 — Herbal medicine for herpes labialis: systematic review (PMID 40526027)
confirms topical Melissa cream evidence base.
View StudyGhazizadeh et al. 2021 — Lemon balm for depression + anxiety in clinical trials: systematic review + meta-analysis (PMID 34449930)
pooled SMD across 12 RCTs.
View StudyMazzanti et al. 2023 — Phospholipid-carrier Melissa officinalis "calming effect" subchronic RCT (PMID 37927585)
phytosome formulation evidence.
View StudyMazzanti et al. 2024 — Phospholipid-carrier Melissa officinalis in vitro neuromodulator profile (PMID 38545418)
mechanistic companion paper.
View Studydopamine.club community profile for lemon balm
516 community reports, dose distribution, stack synergies, leaderboard rankings.
View Studyr/Nootropics oral bioavailability table — rosmarinic acid + caffeic acid
bioavailability reference figures.
View StudyLatest research
- systematic-reviewHerbal Medicine for Treating Herpes Labialis — Systematic ReviewConfirms topical Melissa officinalis (lemon balm) cream as evidence-supported for HSV-1 cold sores; herbal-medicine class B+ evidence in herpes labialis.
- mechanismPhospholipid-carrier Melissa officinalis L. extract — in vitro neuromodulator profileIn vitro mechanistic basis for the phytosome (Relissa) formulation — supports GABAergic and BDNF modulation pathways relevant to emotional distress.
- rctSubchronic phospholipid-carrier Melissa officinalis "calming effect" RCT in emotional distress + poor sleepProspective double-blind RCT — phytosome lemon balm extract showed subjective calming + sleep-quality improvement in adults with mild emotional distress at sub-chronic dosing.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.